semaglutide constipation lawsuit in louisiana lawmakers are considering a bill that would expand Medicaid access to GLP-1 drugs for obesity treatment, a move supporters say could improve health outcomes and reduce long-term costs. https://bit.ly/4usEGVI Louisiana woman sues drug makers
Description
Per week

to test food and pesticides that cross the Mexican border

More serious potential risks include pancreatitis, gallbladder disease, kidney problems related to dehydration, hypoglycemia in certain patient populations, and allergic reactions

Ongoing provider messaging, dosage adjustments, and medication changes are managed through the Gala GLP-1 platform as part of the platform's support structure, subject to the patient's active plan and provider review
A broad, indicative timeline to be interpreted with caution may look as follows: Early weeks of treatment: Fatigue may be most noticeable, coinciding with appetite suppression and initial gastrointestinal adjustment

& Bonifacino, J
